Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19
Abstract The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this “new normal” state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improvin...
Gespeichert in:
| Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2021-01, Vol.106 (1), p.e377-e381 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e381 |
|---|---|
| container_issue | 1 |
| container_start_page | e377 |
| container_title | The journal of clinical endocrinology and metabolism |
| container_volume | 106 |
| creator | Agarwal, Shivani Griffith, Michelle L Murphy, Elizabeth J Greenlee, Carol Boord, Jeffrey Gabbay, Robert A |
| description | Abstract
The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this “new normal” state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improving medical outcomes, patient experience, provider satisfaction, and reducing costs. In this perspective, we discuss several innovative diabetes models of care which promote collaborative care models and improve access to high-quality specialty diabetes care. We discuss ongoing threats to diabetes care innovation, and offer practical solutions to foster evolution and sustain current strides made during the pandemic. |
| doi_str_mv | 10.1210/clinem/dgaa704 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7665547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A702242514</galeid><oup_id>10.1210/clinem/dgaa704</oup_id><sourcerecordid>A702242514</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6284-dd5c8b51d8b44d2b5a4409929e6245bb050e97ea69cbfb27044517b2441bdca33</originalsourceid><addsrcrecordid>eNqFkU9vFCEYxonR2Fq9ejSTeNHDtMDAMFxM6tY_a5r2osYbgZl3dqkMbGGmm976QfTL9ZNIs2v9kxrDgeTl9zzw8CD0lOB9Qgk-aJ31MBx0C60FZvfQLpGMl4JIcR_tYkxJKQX9soMepXSGMWGMVw_RTlVRzBvS7KIPc-_DhR5t8Kmwvjiy2sAIqZjpCEUfYqGL1zCOEIvrq28nsC5OQhy0u776nueXwXfF7PTz_Kgk8jF60GuX4Ml230Of3r75OHtfHp--m88Oj8u2pg0ru463jeGkawxjHTVcM4alpBJqyrgxmGOQAnQtW9MbmlMxToShjBHTtbqq9tCrje9qMgN0LfgxaqdW0Q46XqqgrfrzxNulWoQLJeqacyaywYutQQznE6RRDTa14Jz2EKakKKtJU1MhZUaf_4WehSn6HE9RyWtSC0qqX9RCO1DW9yHf296YqkOBKWWUE5ap_TuovDoYbBs89DbP7xK0MaQUob_NSLC6aV9t2lfb9rPg2e8_c4v_rDsDdAOsg8uVpq9uWkNUS9BuXP7b9eVGFKbV_17wA9AWy1A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2956167213</pqid></control><display><type>article</type><title>Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Agarwal, Shivani ; Griffith, Michelle L ; Murphy, Elizabeth J ; Greenlee, Carol ; Boord, Jeffrey ; Gabbay, Robert A</creator><creatorcontrib>Agarwal, Shivani ; Griffith, Michelle L ; Murphy, Elizabeth J ; Greenlee, Carol ; Boord, Jeffrey ; Gabbay, Robert A</creatorcontrib><description>Abstract
The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this “new normal” state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improving medical outcomes, patient experience, provider satisfaction, and reducing costs. In this perspective, we discuss several innovative diabetes models of care which promote collaborative care models and improve access to high-quality specialty diabetes care. We discuss ongoing threats to diabetes care innovation, and offer practical solutions to foster evolution and sustain current strides made during the pandemic.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/clinem/dgaa704</identifier><identifier>PMID: 33205818</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; Diabetes mellitus ; Diabetes Mellitus - therapy ; Diabetes therapy ; Epidemics ; Evidence-based medicine ; Humans ; Innovations ; Pandemics ; Patient Care Team ; Pharmacists ; Referral and Consultation ; SARS-CoV-2 ; Telemedicine ; Type 2 diabetes</subject><ispartof>The journal of clinical endocrinology and metabolism, 2021-01, Vol.106 (1), p.e377-e381</ispartof><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. 2020</rights><rights>Copyright © Oxford University Press 2015</rights><rights>The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society.</rights><rights>COPYRIGHT 2021 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6284-dd5c8b51d8b44d2b5a4409929e6245bb050e97ea69cbfb27044517b2441bdca33</citedby><cites>FETCH-LOGICAL-c6284-dd5c8b51d8b44d2b5a4409929e6245bb050e97ea69cbfb27044517b2441bdca33</cites><orcidid>0000-0002-7240-8764 ; 0000-0003-4506-3702 ; 0000-0001-7687-2831 ; 0000-0002-2030-7064</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33205818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Agarwal, Shivani</creatorcontrib><creatorcontrib>Griffith, Michelle L</creatorcontrib><creatorcontrib>Murphy, Elizabeth J</creatorcontrib><creatorcontrib>Greenlee, Carol</creatorcontrib><creatorcontrib>Boord, Jeffrey</creatorcontrib><creatorcontrib>Gabbay, Robert A</creatorcontrib><title>Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Abstract
The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this “new normal” state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improving medical outcomes, patient experience, provider satisfaction, and reducing costs. In this perspective, we discuss several innovative diabetes models of care which promote collaborative care models and improve access to high-quality specialty diabetes care. We discuss ongoing threats to diabetes care innovation, and offer practical solutions to foster evolution and sustain current strides made during the pandemic.</description><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 - epidemiology</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus - therapy</subject><subject>Diabetes therapy</subject><subject>Epidemics</subject><subject>Evidence-based medicine</subject><subject>Humans</subject><subject>Innovations</subject><subject>Pandemics</subject><subject>Patient Care Team</subject><subject>Pharmacists</subject><subject>Referral and Consultation</subject><subject>SARS-CoV-2</subject><subject>Telemedicine</subject><subject>Type 2 diabetes</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><sourceid>EIF</sourceid><recordid>eNqFkU9vFCEYxonR2Fq9ejSTeNHDtMDAMFxM6tY_a5r2osYbgZl3dqkMbGGmm976QfTL9ZNIs2v9kxrDgeTl9zzw8CD0lOB9Qgk-aJ31MBx0C60FZvfQLpGMl4JIcR_tYkxJKQX9soMepXSGMWGMVw_RTlVRzBvS7KIPc-_DhR5t8Kmwvjiy2sAIqZjpCEUfYqGL1zCOEIvrq28nsC5OQhy0u776nueXwXfF7PTz_Kgk8jF60GuX4Ml230Of3r75OHtfHp--m88Oj8u2pg0ru463jeGkawxjHTVcM4alpBJqyrgxmGOQAnQtW9MbmlMxToShjBHTtbqq9tCrje9qMgN0LfgxaqdW0Q46XqqgrfrzxNulWoQLJeqacyaywYutQQznE6RRDTa14Jz2EKakKKtJU1MhZUaf_4WehSn6HE9RyWtSC0qqX9RCO1DW9yHf296YqkOBKWWUE5ap_TuovDoYbBs89DbP7xK0MaQUob_NSLC6aV9t2lfb9rPg2e8_c4v_rDsDdAOsg8uVpq9uWkNUS9BuXP7b9eVGFKbV_17wA9AWy1A</recordid><startdate>20210101</startdate><enddate>20210101</enddate><creator>Agarwal, Shivani</creator><creator>Griffith, Michelle L</creator><creator>Murphy, Elizabeth J</creator><creator>Greenlee, Carol</creator><creator>Boord, Jeffrey</creator><creator>Gabbay, Robert A</creator><general>Oxford University Press</general><general>Copyright Oxford University Press</general><scope>TOX</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7T5</scope><scope>7TM</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7240-8764</orcidid><orcidid>https://orcid.org/0000-0003-4506-3702</orcidid><orcidid>https://orcid.org/0000-0001-7687-2831</orcidid><orcidid>https://orcid.org/0000-0002-2030-7064</orcidid></search><sort><creationdate>20210101</creationdate><title>Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19</title><author>Agarwal, Shivani ; Griffith, Michelle L ; Murphy, Elizabeth J ; Greenlee, Carol ; Boord, Jeffrey ; Gabbay, Robert A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6284-dd5c8b51d8b44d2b5a4409929e6245bb050e97ea69cbfb27044517b2441bdca33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 - epidemiology</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus - therapy</topic><topic>Diabetes therapy</topic><topic>Epidemics</topic><topic>Evidence-based medicine</topic><topic>Humans</topic><topic>Innovations</topic><topic>Pandemics</topic><topic>Patient Care Team</topic><topic>Pharmacists</topic><topic>Referral and Consultation</topic><topic>SARS-CoV-2</topic><topic>Telemedicine</topic><topic>Type 2 diabetes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Agarwal, Shivani</creatorcontrib><creatorcontrib>Griffith, Michelle L</creatorcontrib><creatorcontrib>Murphy, Elizabeth J</creatorcontrib><creatorcontrib>Greenlee, Carol</creatorcontrib><creatorcontrib>Boord, Jeffrey</creatorcontrib><creatorcontrib>Gabbay, Robert A</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Agarwal, Shivani</au><au>Griffith, Michelle L</au><au>Murphy, Elizabeth J</au><au>Greenlee, Carol</au><au>Boord, Jeffrey</au><au>Gabbay, Robert A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2021-01-01</date><risdate>2021</risdate><volume>106</volume><issue>1</issue><spage>e377</spage><epage>e381</epage><pages>e377-e381</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><abstract>Abstract
The coronavirus disease pandemic has created opportunities for innovation in diabetes care that were not possible before. From the lens of this “new normal” state, we have an opportunity to rapidly implement, test, and iterate models of diabetes care to achieve the quadruple aim of improving medical outcomes, patient experience, provider satisfaction, and reducing costs. In this perspective, we discuss several innovative diabetes models of care which promote collaborative care models and improve access to high-quality specialty diabetes care. We discuss ongoing threats to diabetes care innovation, and offer practical solutions to foster evolution and sustain current strides made during the pandemic.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>33205818</pmid><doi>10.1210/clinem/dgaa704</doi><orcidid>https://orcid.org/0000-0002-7240-8764</orcidid><orcidid>https://orcid.org/0000-0003-4506-3702</orcidid><orcidid>https://orcid.org/0000-0001-7687-2831</orcidid><orcidid>https://orcid.org/0000-0002-2030-7064</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0021-972X |
| ispartof | The journal of clinical endocrinology and metabolism, 2021-01, Vol.106 (1), p.e377-e381 |
| issn | 0021-972X 1945-7197 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7665547 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Coronaviruses COVID-19 COVID-19 - epidemiology Diabetes mellitus Diabetes Mellitus - therapy Diabetes therapy Epidemics Evidence-based medicine Humans Innovations Pandemics Patient Care Team Pharmacists Referral and Consultation SARS-CoV-2 Telemedicine Type 2 diabetes |
| title | Innovations in Diabetes Care for a Better “New Normal” Beyond COVID-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-03T07%3A30%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Innovations%20in%20Diabetes%20Care%20for%20a%20Better%20%E2%80%9CNew%20Normal%E2%80%9D%20Beyond%20COVID-19&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Agarwal,%20Shivani&rft.date=2021-01-01&rft.volume=106&rft.issue=1&rft.spage=e377&rft.epage=e381&rft.pages=e377-e381&rft.issn=0021-972X&rft.eissn=1945-7197&rft_id=info:doi/10.1210/clinem/dgaa704&rft_dat=%3Cgale_pubme%3EA702242514%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2956167213&rft_id=info:pmid/33205818&rft_galeid=A702242514&rft_oup_id=10.1210/clinem/dgaa704&rfr_iscdi=true |